These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 683746)

  • 1. Reaction of 4-methylumbelliferylguanidinobenzoate with cultivated human skin fibroblasts derived from patients with cystic fibrosis.
    Platt MW; Rao GJ; Nadler HL
    Pediatr Res; 1978 Aug; 12(8):874-7. PubMed ID: 683746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reaction of 4-methylumbelliferylguanidinobenzoate with proteases in human amniotic fluid.
    Walsh MM; Rao GJ; Nadler HL
    Pediatr Res; 1980 Apr; 14(4 Pt 1):353-6. PubMed ID: 6990368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease deficiency in plasma of patients with cystic fibrosis. Reduced reaction of 4-methylumbelliferylguanidinobenzoate with plasma of patients with cystic fibrosis.
    Walsh-Platt M; Rao GJ; Nadler HL
    Enzyme; 1979; 24(4):224-9. PubMed ID: 488055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylumbelliferylguanidinobenzoate-reactive proteases in human amniotic fluid: Promising marker for the intrauterine detection of cystic fibrosis.
    Walsh MM; Nadler HL
    Am J Obstet Gynecol; 1980 Aug; 137(8):978-82. PubMed ID: 6996486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the major 4-methylumbelliferyl p-guanidinobenzoate-hydrolyzing plasma protein in cystic fibrosis: implication for intrauterine and heterozygote detection.
    Branchini BR; Salituro GM; Rosenstein BJ
    Pediatr Res; 1983 Nov; 17(11):850-5. PubMed ID: 6646895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrauterine detection of cystic fibrosis.
    Nadler HL; Walsh MM
    Pediatrics; 1980 Nov; 66(5):690-2. PubMed ID: 7001334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal diagnosis of cystic fibrosis by methylumbelliferylguanidinobenzoate protease titration in amniotic fluid.
    Brock DJ; Hayward C
    Prenat Diagn; 1983 Jan; 3(1):1-5. PubMed ID: 6341979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic study of the hydrolysis of 4-methylumbelliferylguanidinobenzoate in plasma from patients with cystic fibrosis and controls.
    Tümmler B; Seger E; Riordan JR
    Clin Chim Acta; 1982 Oct; 125(2):219-32. PubMed ID: 6754142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reaction of 4-methylumbelliferylguanidinobenzoate with proteases in plasma of patients with cystic fibrosis.
    Rao GJ; Platt MW; Nadler HL
    Enzyme; 1978; 23(5):314-9. PubMed ID: 710382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A serine protease activity of human serum albumin towards 4-methylumbelliferyl-guanidinobenzoate (MUGB) and diisopropyl fluorophosphate (DEP): implications for the use of MUGB reactivity in amniotic fluid in prenatal diagnosis of cystic fibrosis.
    Schwartz M
    Clin Chim Acta; 1982 Sep; 124(2):213-23. PubMed ID: 6754141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced UDP-galactose:glycoprotein galactosyl transferase activity in cultivated skin fibroblasts from patients with cystic fibrosis and its possible relationship to the pathogenesis of the disease.
    Rao GJ; Spells G; Nadler HL
    Pediatr Res; 1977 Sep; 11(9 Pt 1):981-5. PubMed ID: 904986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diamine oxidase activity in fibroblasts from normal and cystic fibrosis patients.
    Gahl WA; Pitot HC
    Pediatr Res; 1980 Feb; 14(2):118-21. PubMed ID: 6767219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal detection of cystic fibrosis.
    Nadler HL; Rembelski P; Meserow K; Gerbie AB
    Am J Obstet Gynecol; 1981 Dec; 141(8):885-9. PubMed ID: 7315920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gaucher disease: accurate identification of asymptomatic French-Canadian carrier using nonlabeled authentic sphingolipid substrate N-palmitoyl dihydroglucocerebroside.
    Choy FY; Bouillon L; Laurin CA
    Am J Med Genet; 1987 Aug; 27(4):895-905. PubMed ID: 3425599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anomalous alpha 2-macroglobulin-protease complexes in cystic fibrosis: decreased uptake of the complexes by fibroblasts in culture.
    Van Leuven F; Cassiman JJ; Van Den Berghe H
    Pediatr Res; 1979 Dec; 13(12):1384-6. PubMed ID: 93265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylumbelliferyl-guanidinobenzoate reactive proteases in amniotic fluid: possible marker for cystic fibrosis.
    Walsh MM; Nadler HL
    Lancet; 1979 Mar; 1(8116):622. PubMed ID: 85228
    [No Abstract]   [Full Text] [Related]  

  • 17. False-negative results with methylumbelliferylguanidinobenzoate reactive proteases in cystic fibrosis pregnancies.
    Schwartz M; Brandt NJ
    Lancet; 1981 Nov; 2(8257):1226. PubMed ID: 6118647
    [No Abstract]   [Full Text] [Related]  

  • 18. Distinguishing homozygous and heterozygous cystic fibrosis fibroblasts from normal cells by differences in sodium transport.
    Breslow JL; McPherson J; Epstein J
    N Engl J Med; 1981 Jan; 304(1):1-5. PubMed ID: 7432432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on cystic fibrosis using isoelectric focusing. II. Demonstration of deficient proteolytic cleavage of alpha2-macroglobulin in cystic fibrosis plasma.
    Wilson GB; Fudenberg HH
    Pediatr Res; 1976 Feb; 10(2):87-96. PubMed ID: 54896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-methylumbelliferylguanidinobenzoate reactive plasma "protease" in cystic fibrosis is albumin.
    Branchini BR; Salituro GM; Rosenstein BJ; Bruns WT
    Lancet; 1982 Mar; 1(8272):618-9. PubMed ID: 6121200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.